Molecular Diagnostics Devices And Equipment Market Forecast Insights: The Road To $48.84 Billion By 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Molecular Diagnostics Devices And Equipment Market Set To Climb From $30.33 Billion In 2026 To $48.84 Billion By 2030
The market for molecular diagnostics devices and equipment has seen considerable expansion recently. This sector is expected to rise from $27.23 billion in 2025 to $30.33 billion in 2026, showing a compound annual growth rate (CAGR) of 11.4%. Historically, this growth can be linked to an increase in infectious disease testing, the widening scope of genetic screening programs, a surge in the application of molecular diagnostics in oncology, advancements in sequencing precision, and greater clinical recognition of molecular testing.
The molecular diagnostics devices and equipment market is anticipated to experience significant growth over the next few years. It is projected to reach $48.84 billion by 2030, advancing at a compound annual growth rate (CAGR) of 12.7%. This growth during the forecast period is fueled by increasing demand for personalized medicine, rising investments in genomic diagnostics, the expansion of decentralized molecular testing, growing adoption of automated sample processing, and a heightened focus on early-stage disease detection. Key trends during this period include the increasing adoption of PCR-based testing platforms, the rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, the expansion of companion diagnostics applications, and an enhanced focus on early and personalized diagnoses.
Get A Free Sample Report With In-Depth Market Insights:
Molecular Diagnostics Devices And Equipment Market Growth Factors Behind Sustained Expansion
The increasing prevalence of infectious diseases is anticipated to fuel the expansion of the molecular diagnostic devices and equipment market moving forward. Such diseases are defined as illnesses resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, which can spread between individuals or from animals to humans. The escalating frequency of infectious diseases is influenced by factors such as antimicrobial resistance, global interconnectedness and travel, urbanization, socioeconomic disparities, and an aging demographic. Molecular diagnostic tools and equipment are vital for the detection and management of these diseases. For instance, data from the Centers for Disease Control and Prevention, a US-based government agency, shows that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, indicating an increase of 1,295 cases. Concurrently, the incidence rate climbed from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Thus, the escalating incidence of infectious diseases is a key driver for the growth of the molecular diagnostic devices and equipment market.
Molecular Diagnostics Devices And Equipment Market Segment Outlook: Which Categories Are Growing Fastest?
The molecular diagnostics devices and equipment market covered in this report is segmented –
1) By Product: Instruments, Reagents And Consumables, Software
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
4) By End User: Diagnostic laboratories, Hospitals, Other End Users
Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation
Molecular Diagnostics Devices And Equipment Market Industry Trends Fueling Future Revenue Growth
Leading companies in the molecular diagnostics devices and equipment market are developing innovative products, such as high-throughput sample-to-result instruments for molecular diagnostics. This high-throughput system will be founded on ELITech’s proven extraction and assay technology. It is designed to use the same reagents as InGenius and BeGenius. As an illustration, in April 2023, ELITechGroup, a France-based company involved in integrated in-vitro diagnostics, unveiled a high-throughput sample-to-result instrument for molecular diagnostics. This instrument facilitates continuous loading of samples and reagents, combined with true random-access capability. Users will have the flexibility to run different PCR reagents, protocols, and sample matrices simultaneously, offering maximum versatility.
Molecular Diagnostics Devices And Equipment Market Top Companies Driving Competitive Growth
Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd
View The Full Molecular Diagnostics Devices And Equipment Market Report:
Molecular Diagnostics Devices And Equipment Market Global Footprint: Which Region Leads The Market?
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
